 |
Plitidepsin |
|---|---|
| Trade Name | Aplidin |
| Orphan Indication | Acute lymphoblastic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2004-06-18 00:00:00 |
| Sponsor | PharmaMar USA, Inc;University Park at M.I.T., Sidney Street;Cambridge, Massachusetts, 02139 |
Related Access Program
Novartis Pharmaceuticals – Acute Lymphoblastic Leukemia
University of California, San Francisco – Acute Lymphoblastic Leukemia
ERYtech Pharma – Acute Lymphoblastic Leukemia
University of California, San Francisco – Acute lymphoblastic leukemia
ERYtech Pharma – Acute lymphoblastic leukemia
Amgen – Acute lymphoblastic leukemia